- Home
- CRMD vs RAPP Comparison
CRMD vs RAPP Comparison
Compare CRMD & RAPP Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- CRMD
- RAPP
- Stock Information
- Founded
- CRMD 2006
- RAPP 2022
- Country
- CRMD United States
- RAPP United States
- Employees
- CRMD N/A
- RAPP N/A
- Industry
- CRMD Biotechnology: Pharmaceutical Preparations
- RAPP
- Sector
- CRMD Health Care
- RAPP
- Exchange
- CRMD Nasdaq
- RAPP Nasdaq
- Market Cap
- CRMD 738.4M
- RAPP 844.6M
- IPO Year
- CRMD 2010
- RAPP 2024
- Fundamental
- Price
- CRMD $12.49
- RAPP $13.27
- Analyst Decision
- CRMD Strong Buy
- RAPP Strong Buy
- Analyst Count
- CRMD 6
- RAPP 4
- Target Price
- CRMD $15.67
- RAPP $37.33
- AVG Volume (30 Days)
- CRMD 1.3M
- RAPP 112.9K
- Earning Date
- CRMD 03-11-2025
- RAPP 02-10-2025
- Dividend Yield
- CRMD N/A
- RAPP N/A
- EPS Growth
- CRMD N/A
- RAPP N/A
- EPS
- CRMD N/A
- RAPP N/A
- Revenue
- CRMD $12,262,234.00
- RAPP N/A
- Revenue This Year
- CRMD N/A
- RAPP N/A
- Revenue Next Year
- CRMD $246.41
- RAPP N/A
- P/E Ratio
- CRMD N/A
- RAPP N/A
- Revenue Growth
- CRMD 41184.20
- RAPP N/A
- 52 Week Low
- CRMD $2.89
- RAPP $12.10
- 52 Week High
- CRMD $13.85
- RAPP $29.74
- Technical
- Relative Strength Index (RSI)
- CRMD 70.88
- RAPP N/A
- Support Level
- CRMD $7.91
- RAPP N/A
- Resistance Level
- CRMD $13.09
- RAPP N/A
- Average True Range (ATR)
- CRMD 0.70
- RAPP 0.00
- MACD
- CRMD 0.43
- RAPP 0.00
- Stochastic Oscillator
- CRMD 88.68
- RAPP 0.00
About CRMD CorMedix Inc.
Cormedix Inc is a biopharmaceutical company focused on developing and commercializing therapeutic products for the prevention and treatment of infectious and inflammatory diseases. The Company's focus is on the commercialization of its product, DefenCath, in the United States (U.S.) and other key markets.
About RAPP Rapport Therapeutics Inc. Common Stock
Rapport Therapeutics Inc is a clinical-stage biopharmaceutical company focused on discovery and development of transformational small-molecule medicines for patients suffering from central nervous system disorders. Its foundational science has elucidated the complexities of neuronal receptor biology and enables the company to map and target certain neuronal receptor complexes. Neuronal receptors are complex assemblies of proteins, comprising receptor principal subunits and their receptor-associated proteins (RAPs), the latter of which play crucial roles in regulating receptor expression and function.